Ardelyx ARDX Licensing revenue — Total revenues
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Ardelyx in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Ardelyx’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ardelyx's licensing revenue — total revenues.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ardelyx's licensing revenue — total revenues?
- Ardelyx (ARDX) reported licensing revenue — total revenues of $51K in Q1 2026.
- How has Ardelyx's licensing revenue — total revenues changed year-over-year?
- Ardelyx's licensing revenue — total revenues decreased by 99.0% year-over-year, from $5.02M to $51K.
- What is the long-term trend for Ardelyx's licensing revenue — total revenues?
- Over 4 years (2021 to 2025), Ardelyx's licensing revenue — total revenues has grown at a 0.4% compound annual growth rate (CAGR), from $5.01M to $5.09M.
- What does licensing revenue — total revenues mean?
- This metric represents the aggregate revenue recognized from licensing agreements within a specific business segment. It reflects the company's ability to monetize its intellectual property and proprietary drug discovery platform through partnerships. Investors use this to gauge the commercial success and recurring nature of licensing-based business models.